NCT06732856 2025-07-28
NEO-CLAUD
Asan Medical Center
Phase 1/2 Recruiting
Clinical Trials
16 trialsNCT07025889 2025-06-18
IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer
Ruijin Hospital
Phase 1/2 Recruiting
NCT05218889 2024-12-31
Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
Chinese PLA General Hospital
Phase 1/2 Recruiting
NCT03991104 2023-09-21
SOX-based CRT for Esophageal Cancer.
Zhejiang Provincial People's Hospital
Phase 1/2 Withdrawn
NCT02564367 2021-04-29
S-1 adjuvant
AIO-Studien-gGmbH
Phase 1/2 Completed
NCT04781413 2021-03-04
Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer
Ruijin Hospital
Phase 1/2 Unknown
NCT03654612 2018-10-18
Y-HR2017-025
China International Medical Foundation
Phase 1/2 Unknown
NCT01783951 2018-07-19
Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer
Capital Medical University
Phase 1/2 Completed
NCT01781520 2018-01-18
Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer
Capital Medical University
Phase 1/2 Completed
NCT01110941 2015-05-19
SCI-101
Peking University
Phase 1/2 Completed
NCT01106066 2013-06-14
Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT
Samsung Medical Center
Phase 1/2 Terminated
NCT01227239 2012-11-27
Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting
Japan Clinical Cancer Research Organization
Phase 1/2 Unknown
NCT00209729 2010-05-26
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
Hokkaido Gastrointestinal Cancer Study Group
Phase 1/2 Suspended
NCT00524706 2008-11-13
Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer
Shizuoka Cancer Center
Phase 1/2 Unknown
NCT00209677 2007-11-01
Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 1/2 Suspended
NCT00209638 2006-04-21
Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 1/2 Completed